For patients with diabetes, ticagrelor reduced heart attacks, strokes: Benefits particularly favorable in patients with prior coronary artery stenting; patients also experienced increased risk of bleeding

In late-breaking clinical trial results presented in a Hot Line Session today at the European Society of Cardiology Congress 2019, investigators from Brigham and Women’s Hospital and Greater Paris University Hospitals — AP-HP/Université de Paris presented the results from The Effect of Ticagrelor on Health Outcomes in Diabetes Mellitus Patients Intervention Study (THEMIS), a clinical trial sponsored by AstraZeneca that […]

Read more

Augmented reality glasses may help people with low vision better navigate their environment: Glasses enhance mobility and function in patients who have difficulty with peripheral vision or seeing in low light

Nearly one in 30 Americans over the age of 40 experience low vision — significant visual impairment that can’t be corrected with glasses, contact lenses, medication or surgery. In a new study of patients with retinitis pigmentosa, an inherited degenerative eye disease that results in poor vision, Keck School of Medicine of USC researchers found that adapted augmented reality (AR) […]

Read more

Maximising alertness and productivity on the nightshift

If you’re one of Australia’s 1.4 million shiftworkers, eating at irregular times is just par for the course — but have you ever stopped to think about the impact this might have on your body? In a new research study by the University of South Australia, researchers have investigated whether altering food intake during the nightshift could optimise how shiftworkers […]

Read more

Alzheimer’s protein is likely held together with many weak chemical interactions: Model reveals new role for overlooked electron relationships

The chemical interactions that give proteins their shape may be weaker and more numerous than previously recognized. These weak connections provide a new way for researchers to understand proteins that cause disease and help them gain insights into the fundamentals of chemistry. Chemists at the University of Tokyo modeled the building blocks of the protein structure that causes Alzheimer’s disease, […]

Read more

Patients with or without cancer use different forms of marijuana, study finds

People with and without cancer are more likely, over time, to use a more potent form of medical marijuana with increasingly higher amounts of tetrahydrocannabinol (THC), a new study shows. In a report publishing in the Journal of Palliative Medicine on March 26, researchers say that cancer patients were more likely to favor forms of medical marijuana with higher amounts […]

Read more

Selma Blair Discusses Multiple Sclerosis, and Many Hear Their Own Story

The actress Selma Blair appeared at the Vanity Fair Oscar party on Sunday evening wearing a diaphanous Ralph & Russo gown and carrying a custom-made cane covered in black patent leather. It was her first public event since she announced in October her diagnosis of multiple sclerosis, a chronic and often disabling disease affecting the central nervous system. In an […]

Read more

After naloxone, when can opioid overdose patients be safely discharged? Study confirms one hour rule

  Naloxone has saved thousands of lives. But can patients be safely discharged from the Emergency Department (ED) just an hour after they receive the medication that curtails drug overdoses? According to the St. Paul’s Early Discharge Rule developed in 2000, that’s how long providers should observe patients after naloxone treatment, so long as their vital signs meet specific criteria […]

Read more

Biologists identify promising drug for ALS treatment

A new drug could significantly slow the progression of ALS, also known as Lou Gehrig’s disease, according to new research by University of Alberta biologists. Current treatments slow progression of the degenerative disease by only a few months, and these findings could revolutionize the treatment of patients suffering from ALS, extending and improving quality of life. The drug, called telbivudine, […]

Read more